1. Home
  2. HCM vs SFNC Comparison

HCM vs SFNC Comparison

Compare HCM & SFNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCM
  • SFNC
  • Stock Information
  • Founded
  • HCM 2000
  • SFNC 1903
  • Country
  • HCM Hong Kong
  • SFNC United States
  • Employees
  • HCM N/A
  • SFNC N/A
  • Industry
  • HCM Biotechnology: Pharmaceutical Preparations
  • SFNC Major Banks
  • Sector
  • HCM Health Care
  • SFNC Finance
  • Exchange
  • HCM Nasdaq
  • SFNC Nasdaq
  • Market Cap
  • HCM 2.5B
  • SFNC 2.2B
  • IPO Year
  • HCM N/A
  • SFNC N/A
  • Fundamental
  • Price
  • HCM $14.84
  • SFNC $18.26
  • Analyst Decision
  • HCM Hold
  • SFNC Hold
  • Analyst Count
  • HCM 1
  • SFNC 3
  • Target Price
  • HCM $19.00
  • SFNC $22.00
  • AVG Volume (30 Days)
  • HCM 90.6K
  • SFNC 523.3K
  • Earning Date
  • HCM 07-30-2025
  • SFNC 07-23-2025
  • Dividend Yield
  • HCM N/A
  • SFNC 4.67%
  • EPS Growth
  • HCM N/A
  • SFNC N/A
  • EPS
  • HCM 0.04
  • SFNC 1.16
  • Revenue
  • HCM $630,201,000.00
  • SFNC $726,747,000.00
  • Revenue This Year
  • HCM $14.86
  • SFNC $22.95
  • Revenue Next Year
  • HCM $19.54
  • SFNC $6.32
  • P/E Ratio
  • HCM $66.84
  • SFNC $15.69
  • Revenue Growth
  • HCM N/A
  • SFNC N/A
  • 52 Week Low
  • HCM $11.51
  • SFNC $16.29
  • 52 Week High
  • HCM $21.50
  • SFNC $25.95
  • Technical
  • Relative Strength Index (RSI)
  • HCM 46.89
  • SFNC 39.98
  • Support Level
  • HCM $15.02
  • SFNC $18.04
  • Resistance Level
  • HCM $18.00
  • SFNC $18.47
  • Average True Range (ATR)
  • HCM 0.42
  • SFNC 0.40
  • MACD
  • HCM -0.04
  • SFNC -0.07
  • Stochastic Oscillator
  • HCM 31.45
  • SFNC 16.18

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About SFNC Simmons First National Corporation

Simmons First National Corp is a financial holding company. The company through its subsidiaries is engaged in providing banking services including consumer, real estate and commercial loans, checking, savings and time deposits. The company's loan portfolio comprises construction, single-family residential and commercial loans; non-real estate loans, nonaccrual and past due loans; and credit card loans, student loans and other consumer loans. It also offers various products and services such as trust services, investments, agricultural finance lending, equipment lending, insurance, consumer finance and small business administration lending. The business activity of the firm is functioned through the region of the United States.

Share on Social Networks: